Results 271 to 280 of about 117,595 (294)

ALS antisense drug falters in phase III

Nature Reviews Drug Discovery, 2021
exaly  

Antisense Oligonucleotide

2006
openaire   +1 more source

An Antisense Oligonucleotide Primer

Antisense and Nucleic Acid Drug Development, 1999
openaire   +2 more sources

Antisense therapy targeting apolipoprotein(a): a randomised, double-blind, placebo-controlled phase 1 study

Lancet, The, 2015
Sotirios Tsimikas, Joseph L Witztum
exaly  

Antisense Oligonucleotides

2017
openaire   +1 more source

Antisense oligonucleotides targeting apolipoprotein(a) in people with raised lipoprotein(a): two randomised, double-blind, placebo-controlled, dose-ranging trials

Lancet, The, 2016
Stanley T Crooke, Joseph L Witztum, Sotirios Tsimikas   +2 more
exaly  

The antisense antigen switch

Nature Reviews Microbiology, 2015
Naomi Attar
exaly  

ANTISENSE DRUG ENHANCES RESPONSE IN CHEMORESISTANT MELANOMAS

Ca-A Cancer Journal for Clinicians, 2001
exaly  

Gene regulation by antisense transcription

Nature Reviews Genetics, 2013
Vicent Pelechano, Lars M Steinmetz
exaly  

Eukaryotic antisense ahead of its time

Nature Reviews Molecular Cell Biology, 2016
Lynne E Maquat
exaly